Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,935 | 91,253 | 65,396 | 83,572 | 61,575 |
| Marketable Securities | 290,109 | 257,902 | 263,010 | 265,522 | 314,073 |
| TOTAL | $343,857 | $355,163 | $332,012 | $352,083 | $376,869 |
| Non-Current Assets | |||||
| PPE Net | 288 | 253 | 174 | 159 | 162 |
| Investments And Advances | 142,539 | 151,763 | 23,053 | 23,953 | 18,069 |
| Other Non-Current Assets | 1,933 | 2,072 | 2,179 | 917 | 919 |
| TOTAL | $144,760 | $154,088 | $25,406 | $25,029 | $19,150 |
| Total Assets | $488,617 | $509,251 | $357,418 | $377,112 | $396,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,164 | 2,216 | 4,783 | 4,362 | 9,484 |
| Accrued Expenses | 10,591 | 8,648 | 3,578 | 5,663 | 3,346 |
| Other current liabilities | N/A | 9,684 | 3,089 | 1,415 | N/A |
| TOTAL | $15,374 | $20,967 | $12,110 | $11,723 | $13,043 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,313 | 1,493 | 1,666 | 664 | 755 |
| TOTAL | $1,313 | $1,493 | $1,666 | $664 | $755 |
| Total Liabilities | $16,687 | $22,460 | $13,776 | $12,387 | $13,798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,543 | 48,409 | 37,451 | 37,441 | 37,441 |
| Common Shares | 49 | 48 | 37 | 37 | 37 |
| Retained earnings | -189,157 | -159,574 | -129,297 | -104,723 | -83,724 |
| Other shareholders' equity | 3,477 | 3,116 | 2,904 | 2,925 | 2,890 |
| TOTAL | $471,930 | $486,791 | $343,642 | $364,725 | $382,221 |
| Total Liabilities And Equity | $488,617 | $509,251 | $357,418 | $377,112 | $396,019 |